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ABSTRACT
Objective: To evaluate how distinct presentations of anxiety symptoms and intellectual impair-
ment influence the measurement and estimated rate of clinically significant anxiety in autism
spectrum disorder (ASD).
Method: The sample included 75 children (ages 9–13 years) with ASD and varied IQ and 52
typically developing (TD) controls and parents. Parents completed anxiety symptom scales and
a diagnostic interview, designed to (1) differentiate anxiety and ASD and (2) examine DSM-
specified and unspecified (“distinct”) anxiety presentations in each child, including fears of
change, special interests, idiosyncratic stimuli and social confusion rather than evaluation.
Children completed standard intellectual and ASD diagnostic assessments.
Results: 69% of those with ASD had clinically-significant anxiety, including 21% DSM-specified
anxiety disorders, 17% distinct anxiety, and 31% both. Only 8% of TD children had clinically-
significant anxiety, all DSM-specified. DSM-specified anxiety disorders in children with ASD and
intellectual impairment (IQ<70) were predominantly specific phobias. DSM-specified anxiety other
than specific phobia was significantly less common in children with, versus without, intellectual
impairment; this was not the case for distinct anxiety. The sensitivities of anxiety scales were
moderate to poor, particularly in cases with intellectual impairment.
Conclusions: ASD is associated with more frequent and varied presentations of clinical anxiety,
which may align with and differ from the specified anxiety disorders of the DSM. Standard parent
report anxiety scales have reduced sensitivity to detect clinical anxiety in ASD, particularly in
children with intellectual impairment.
“This summer [1937] we brought him to a playground
slide and on the first afternoon when the other chil-
dren were sliding on it he would not get about it, and
when we put him up to slide down it he seemed
horrorstruck. The next morning when nobody was
present, however, he walked out, climbed the ladder,
and slid down and he has slid on it frequently since,
but slides only when no other child is present to join
him in sliding.”
Case 1, “Donald”
“He frets when the bread is put in the oven to be made
into toast, and is afraid it will get burned and be hurt.
He is upset when the sun sets. He is upset because the
moon does not always appear in the sky at night.”
Case 8, “Alfred”
Autistic Disturbances of Affective Contact by Leo
Kanner, 1943
Autism spectrum disorder (ASD) is a neurodevelop-
mental disorder that affects approximately 1–2% of chil-
dren (Baio et al., 2018). Key features of the disorder, first
described by Kanner (1943), include deficits in social com-
munication and reciprocity and restricted or repetitive
interests and behaviors, which often have a preoccupying
quality that may exacerbate social disadvantages. Anxiety
and obsessive-compulsive symptoms have also long been
observed in children with ASD, so much so that there has
been debate regarding whether these symptoms should be
considered core aspects of ASD rather than co-occurring
disorders (Kerns & Kendall, 2012; Wood & Gadow, 2010).
The present study investigated the premise that the beha-
vioral overlap of anxiety and autism and, further, the dis-
tinct presentation of fears in autism complicate the
assessment of these conditions and their empirical
investigation.
The struggle to differentiate anxiety and ASD is obser-
vable in Kanner’s initial cases (Kanner, 1943). “Donald” is
described as willing and able to play on a slide when alone,
but “horrorstruck” by the presence of other children. His
avoidance of children may reflect social disinterest,
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consistent with ASD or, as Kanner suggests, a horror or
fear of other children, more consistent with anxiety. This
fear may be of negative evaluation (consistent with social
anxiety disorder; SAD) or converge around other ASD-
related challenges–for example, difficulties and subse-
quent anxiety around anticipating and interpreting social
behavior. These latter fears could be conceptualized as
secondary symptoms of ASD or instead as symptoms of
an anxiety disorder, the presentation of which is distinct
and shaped by the individual characteristics of children
with ASD and their experiences. A similar conundrum is
observable in the case of Alfred, who worries constantly (a
symptom of generalized anxiety disorder; GAD), but
whose worries are idiosyncratic and focused on changes,
even those as quotidian as the setting of the sun and
moon. Challenges also arise around the differentiation
of sensory sensitivities and specific phobias of common
(e.g., fear of loud sounds) and uncommon focus (e.g.,
fears of specific songs, toilets, beards), and around the
classification of excessive fears that are circumscribed
around a specialized or perseverative interest (Gjevik,
Eldevik, Fjæran-Granum, & Sponheim, 2011; Kerns
et al., 2014; Leyfer et al., 2006; Mayes et al., 2013). These
fears also are closely aligned with ASD-related chal-
lenges–in this case, restricted and repetitive behaviors/
interests (e.g., sensory differences, insistence on sameness,
circumscribed interests) rather than social communica-
tion deficits. As such, they also appear to sit at the inter-
section of ASD and anxiety, raising questions for
clinicians and researchers alike about how these symp-
toms should be characterized (Kerns & Kendall, 2012;
Kerns et al., 2014).
Studies consistently suggest that children with ASD
are more likely to develop problematic anxiety than
other high-risk groups and experience poorer outcomes
when co-occurring anxiety is present (Chiang & Gau,
2016; Eussen et al., 2013; Kerns et al., 2015; van
Steensel, Bögels, & Dirksen, 2012). Findings are far
less clear; however, about the proportion of children
with ASD likely to develop clinically significant anxiety,
which children are most at risk, and what the quality of
their fears will be. One sign of this lack of clarity is that
studies to date suggest that between 11–84% of children
with ASD may experience clinically significant anxiety
(Kerns & Kendall, 2012). Though studies of diagnosed
anxiety disorders (rather than clinically significant
symptoms) suggest a tighter range of 42 – 55%, which
types of anxiety disorders are most common in ASD is
unclear (de Bruin, Ferdinand, Meester, de Nijs, &
Verheij, 2007; Kerns et al., 2014; Gjevik et al., 2011;
Leyfer et al., 2006; Muris, Steerneman, Merckelbach,
Holdrinet, & Meesters, 1998; Simonoff et al., 2008).
Specific phobia, GAD and SAD appear among the
most common. Obsessive compulsive disorder (OCD),
which has been studied alongside the anxiety disorders,
is also more common in some studies (Leyfer et al.,
2006), but not all (de Bruin et al., 2007). However,
specific estimates vary widely across studies, even
when structured diagnostic interviews are used.
Kerns and Kendall (2012) suggest that this varia-
bility may be due, in part, to discrepancies in the
differential diagnosis and operationalization of anxi-
ety disorders, including distinct presentations of
anxiety, operationalized as anxiety symptoms that
are associated with distress and functional impair-
ment, but which are qualitatively different from the
specified anxiety disorders of the DSM. For example,
though SAD has been reported to occur in close to
30% of children with ASD in some studies, rates are
lower in studies in which fear of negative evaluation
was required (8%; Kerns et al., 2014; Leyfer et al.,
2006). In a sample of verbally-fluent children with
ASD, Kerns et al. (2014) found that although 26%
experienced clinically significant fears of social situa-
tions, only 17% met criteria for SAD. The remaining
9% had limited awareness of social evaluation and
thus fell short of diagnostic criteria. As another
example, Leyfer et al. (2006) observed that the rate
of OCD in their sample (37%) would have been
substantially lower – as has been the case in other
studies (2– 8.2%; de Bruin et al., 2007; Kerns et al.,
2014; Simonoff et al., 2008) – if they had not allowed
parents to make inferences about their children’s
internal states. Muris et al. (1998) also found that
though the vast majority (72%) of children with ASD
in their study displayed ritualistic behavior, few met
diagnostic criteria for OCD due to their parent’s
inability to determine if these behaviors were
distressing.
The literature is also equivocal on which children
with ASD are most likely to develop clinically sig-
nificant anxiety and this may also be explained, in
part, by how anxiety symptoms are operationalized
and assessed. For example, whereas some studies
suggest that higher IQ is associated with greater
anxiety symptoms (Mayes, Calhoun, Murray, &
Zahid, 2011; Sukhodolsky et al., 2008), this finding
has not been universal and a meta-analysis concluded
that lower mean IQ was associated with greater anxi-
ety in ASD (van Steensel, Bögels, & Perrin, 2011).
Kerns and Kendall (2012) proposed that cognitive
ability may be more predictive of anxiety quality
than quantity. Specifically, they hypothesized that
clinically significant anxiety may be equally prevalent
in children with ASD with and without intellectual
impairment when varied forms of anxiety are
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considered, including those that are more behavioral
(e.g. phobic avoidance) or distinct in quality (e.g.,
idiosyncratic fears, social fears without fears of eva-
luation). A test of this hypothesis in a sample of
children with ASD and varied IQ has yet to be con-
ducted and motivated the present study.
Finally, the vast majority of studies of anxiety in
ASD have relied on parent report measures of anxi-
ety rather than semi-structured interviews. The abil-
ity of these brief assays to differentiate ASD and
anxiety symptoms and capture distinct presentations
of anxiety in ASD may be limited given that most
measures were developed and validated for children
without ASD. Moreover, brief questionnaires do not
allow for clinical clarification or judgment. Several
reviews have noted that studies using questionnaires
tend to yield lower estimates of anxiety in ASD than
those using interviews, though this again may vary
based on the form of anxiety being measured (Kerns
& Kendall, 2012; van Steensel et al., 2011). For exam-
ple, estimates of social anxiety appear higher in ques-
tionnaire versus interview studies, potentially due to
poor differentiation in questionnaires of social diffi-
culties due to anxiety versus other deficits in ASD. It
is also notable that many commonly used anxiety
scales were not designed for youth with intellectual
disability. The detection of anxiety in children with
ASD and lower cognitive abilities may thus be parti-
cularly poor when relying on this method of mea-
surement. Consistent with these hypotheses, some
studies suggest that the latent structure of anxiety
as assessed by parent questionnaires is distinct in
children with versus without ASD, particularly
amongst children with ASD and co-occurring intel-
lectual disability (Dovgan, Mazurek, & Hansen, 2019;
White et al., 2015). Studies also suggest that agree-
ment between questionnaires and interviews may be
reduced, even in more cognitively-able children with
ASD (Kerns et al., 2015). How these brief assays
perform relative to a semi-structured interview in
a more cognitively representative sample of children
with ASD would add to this literature.
The primary aims of this study were to (1) com-
pare the quality and quantity of clinically significant
anxiety (both DSM-specified and distinct) in children
with ASD versus typically-developing controls (TD)
using a semi-structured interview adapted for ASD;
(2) assess for differences in the quantity and quality
of anxiety symptoms of children with ASD without
versus with intellectual impairment (defined as
IQ<70); and (3) compare the results of the adapted
interview to brief assays of anxiety.
Methods
Participants
Participants included 127 primary caregivers and their
children (ages 9–13 years) – 75 with a diagnosis of ASD
and 52 age-matched typically developing controls (TD).
All were recruited as part of the Autism Phenome Project,
an ongoing longitudinal research study focused on neu-
rological and behavioral development in ASD. ASD par-
ticipants and TD controls were recruited through the UC
Davis MIND Institute subject database and through
advertisements at regional schools, Parent Teacher
Associations and pediatrician’s offices. From
2006– 2012, 404 children with ASD or TD were enrolled
at ages 2–3.5 years of age for a comprehensive battery
including behavioral, medical, and biological assessments.
To be eligible, children were required to have no signifi-
cant motor delays, vision or hearing problems, be ambu-
latory and to have one biological parent who spoke
English and was willing to participate. All children in
the ASD group were required to (a) meet the ASD cutoff
score on the Autism Diagnostic Observation Schedule,
Generic (ADOS-G) and (b) to meet the Autism
Diagnostic Interview-Revised (ADI-R) full criteria for
autism or (c) to meet on either the ADI-R Social or
Communication Domains and to fall within 2 points of
the other domain per Collaborative Programs of
Excellence in Autism (CPEA) guidelines. Participants
were excluded from TD if they showed verbal or perfor-
mance reasoning deficits of > 2 SDs from the mean. In
addition, the TD controls were screened and excluded for
ASD with the Social Communication Questionnaire–
Lifetime Edition (scores > 11).
Participants who met eligibility criteria and success-
fully completed both behavioral and neuroimaging pro-
tocols at T1 (n = 277) were followed for up to 3 additional
time points through early and middle childhood; partici-
pants who missed a time point continued to be invited to
subsequent time points (Time 2, n = 211; Time 3 n = 183;
Time 4, n = 132 with recruitment ongoing). The subset of
127 children in this study were those who had successfully
completed a diagnostic anxiety assessment at Time 4
(N = 132), which occurred between ages 9– 13 years.
A diagnostic anxiety assessment was not conducted
prior to this time point, given research suggesting that
the onset of most anxiety disorders occurs in middle
childhood or later (Beesdo, Knappe, & Pine, 2009). Five
children were excluded due to changes in diagnosis
between initial enrollment and middle childhood (2
enrolled as TD and later received an ASD diagnosis; 3
enrolled as ASD but no longer met ADOS criteria in
middle childhood).
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Measures
Cognitive Ability
Intellectual functioning was assessed primarily via the
Differential Abilities Scale, Second Edition, School Age or
Early Years Batteries (DAS-II; Elliot, 2007). The DAS-II is
a comprehensive assessment of intellectual abilities appro-
priate for children ages 5 and older. Participants unable to
complete the DAS-II School Year protocols, were instead
administered the DAS-II Early Year battery. The DAS-II
General Conceptual Ability (GCA) index was used as an
estimate of full-scale IQ. Children with GCA < 70 were
considered to have intellectual impairment.
Autism Spectrum Disorder
ASD status and severity was re-assessed at Time 4 via
the Autism Diagnostic Observation Schedule–Second
Edition (ADOS-2; Lord et al., 2012), a semi-structured
behavioral observation of social and communication
deficits indicative of ASD. In addition to a diagnostic
cutoff of ASD, the ADOS-2 yields a Calibrated Severity
Score (CSS) that allows comparison of ASD severity
across individuals with varied functional and verbal
abilities (Gotham, Pickles, & Lord, 2009). ASD-status
was also confirmed at study entry via the ADI-R (Lord,
Rutter, & Le Couteur, 1994), a structured parent inter-
view of ASD with inter-rater reliability and validity
(Rutter, Bailey, & Lord, 2003). Interviewers were
trained to research reliability standards on both the
ADI-R and ADOS-2.
Anxiety
The Anxiety Disorders Interview Schedule–IV–Parent
Interview (ADIS–P; Albano & Silverman, 1996) is
a semi-structured interview conducted with parents to
assess the presence of childhood anxiety disorders with
strong inter-rater and test-retest reliability (Lyneham,
Abbott, & Rapee, 2007; Silverman, Saavedra, & Pina,
2001). In this study, we used the ADIS-P modules for
OCD, separation, social, and generalized anxiety disor-
ders, and specific phobia. Each module receives
a clinical severity rating (CSR), from 0 (no interference)
to 8 (severe interference), with 4 representing the cutoff
for significant interference, and–when all other criteria
are met–diagnosis. Importantly, the reformation of
anxiety disorders from DSM-IV to DSM-5 was focused
on the re-organization of chapter structures rather than
changes to diagnostic criteria. As such, the ADIS-IV-P
assesses all DSM-5 diagnostic criteria for specific pho-
bia, social, separation and generalized anxiety as well as
OCD, though OCD is now listed under a separate
chapter in DSM-5 (Kupfer, 2015). Though both parent
and child interviews are typically preferred, studies on
the ADIS in children with ASD suggest that parent and
child agreement is limited and clinicians often base
diagnostic impressions on parent reports (Storch
et al., 2012). Given this, and the limited verbal abilities
of some participants, this study used only the ADIS-P.
The Autism Spectrum Addendum (ASA; Kerns,
Renno, Kendall, Wood, & Storch, 2017) is a series of
prompts and guidelines that are woven into the ADIS
protocol to tailor the instrument for children with ASD.
The ADIS/ASA gathers additional information about
the child’s developmental level, social functioning and
motivation, experiences and environment, sensory sen-
sitivities and preservative cognitive style. This informa-
tion is used to guide differential diagnosis of symptoms
and estimations of the impairment due to anxiety as
opposed to other difficulties (e.g., communication chal-
lenges, ASD-related social deficits). For example, guide-
lines for the differentiation of social avoidance due to
anxiety versus ASD-related deficits in social motivation
are provided. Guidelines for differentiating ASD-
related perseveration or repetitive thinking from
worry, and specific phobias from sensory sensitivities
are also included. A copy of the manual and standards
for research use and training can be obtained from the
first author.
The ASA also allows interviewers to assess for
“distinct” manifestations of anxiety that commonly
arise in ASD, but do not match the anxiety disorders
specified by the DSM. A CSR from 0 to 8 is assigned
with 4 marking the cutoff for symptoms that cause
interference and are considered “clinically significant”
(herein referred to as “clinical”). Distinct anxiety
types include “idiosyncratic fears” (e.g. fears of toilets,
specific sounds, glasses, beards), “other social fears”
which include social fears related to social confusion
rather than fear of negative evaluation, “special inter-
est fears” (i.e. excessive worry or anxiety related to
perseverative interests), “fears of change” (i.e., chil-
dren with anxious anticipation of and distress follow-
ing changes or novelty) or “negative reactions to
change” (i.e., children with distress following change,
but who do not have anticipatory fears), and “ambig-
uous compulsive symptoms” which capture compul-
sions or rituals that were associated with negative
rather than positive affect, but which could not be
clearly identified as being used to “prevent or neutra-
lize” distress consistent with DSM-IV and DSM-5
OCD criteria. Negative reactions to change are not
conceptualized as symptoms of anxiety given the lack
of an anticipatory component, but are frequently
endorsed and thus measured to provide a more com-
plete picture of this difficulty. Interfering symptoms
in this domain are measured apart from the DSM-
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specified and distinct anxiety symptoms as it is
unclear if they reflect true anxiety or rather broad
difficulties with emotion regulation or flexibility.
Studies of this tailored diagnostic approach support the
convergent and discriminant validity of the measure and
indicate strong inter-rater reliability of CSRs
(ICC = .85–.99) and diagnoses (Cohen’s K = .67–.90) and
2-week retest reliability of CSRs (.77–1.00) and diagnoses
(100% exact agreement) amongst trained evaluators (Kerns
et al., 2014, 2017). All interviewers were trained to criterion
for this study. Specifically, training included readings and
didactic training on the ADIS/ASA and differential diag-
nosis of anxiety and ASD, observation and dual coding of
ADIS/ASA administrations by a reliable interviewer and
administration under the supervision of a reliable inter-
viewer. To be considered reliable, all interviewers were
required to independently agree on all diagnoses and
assigned CSRs within one point of the assigned CSRs of
a reliable trainer (the first author). In addition, continued
reliabilitywas ensured viaweeklymeetings of the evaluators
and training in which cases were reviewed and discussed.
The Child Behavior Checklist/6–18 years (CBCL;
Achenbach & Ruffle, 2000) is a standardized parent-
report questionnaire of positive and problematic beha-
viors in children with established psychometric properties
(Achenbach & Ruffle, 2000). The CBCL includes both
Syndrome Scales, which are referred to as empirically-
based scales and capture clusters of different types of
problem behaviors derived by factor analysis, and DSM-
oriented Scales, which were constructed based on expert
clinician determinations of problem behaviors best char-
acterizing different DSM disorders. Given our focus on
the DSM-derived anxiety, we elected to examine the
DSM-oriented Anxiety Problems Scale. Our focus was
on individuals with T-Scores of 65 or greater indicating
an elevated risk for anxiety disorder. Though the psycho-
metric properties of the CBCL syndrome scales have been
mixed (Medeiros, Mazurek, & Kanne, 2017; Pandolfi,
Magyar, & Dill, 2012), a recent study of 93 well-
characterized youth with ASD and varied intellectual
functioning found that the DSM Anxiety Problems scale
had high internal consistency (.81) and correlated r = .66
with the severity of anxiety as assessed by a semi-
structured diagnostic interview (Magyar & Pandolfi,
2017). Internal consistency of the Anxiety Problems
scale was α = .71 in both the ASD and TD groups
(α = .74 overall).
Multidimensional Anxiety Scale for Children,
Parent Report (MASC-P; March, Parker, Sullivan,
Stallings, & Conners, 1997) is a 39-item standardized
parent-report questionnaire of child anxiety symp-
toms that yields a total anxiety symptom score that
includes items related to harm avoidance, physical
symptoms, social anxiety and separation anxiety. It
demonstrates strong internal consistency, retest sta-
bility, and a reliable 4-factor structure, convergent
validity and clinical sensitivity in research in children
without ASD with a T-Score of 65 or greater indicat-
ing clinically significant symptoms. There is some
support for internal consistency (.92) and discrimi-
nant validity of the MASC in cognitively-able, anxiety
treatment-seeking samples of children with ASD
(Renno & Wood, 2013; White, Schry, & Maddox,
2012), but White et al. (2015) found metric invar-
iance when comparing the factor structure of the
MASC in cognitively-able anxious children with ver-
sus without ASD. Studies of the MASC in children
with ASD and low IQ are lacking.
Screen for Child Anxiety and Related Emotional
Disorders, Parent Report (SCARED-P; Birmaher et al.,
1999) is a 41-item parent-report questionnaire of child
anxiety symptoms that yields a total anxiety score that
includes items related to somatic symptoms, general-
ized anxiety, separation anxiety, social phobia, and
school phobia. In studies of outpatient psychiatric sam-
ples, the SCARED has demonstrated good convergent
and divergent validity, sensitivity (.71) and specificity
(.67). A total cutoff of 25 is considered optimal for
detecting clinically significant anxiety (Birmaher et al.,
1999). Stern, Gadgil, Blakeley-Smith, Reaven, and
Hepburn (2014) also found acceptable internal consis-
tency (.92), sensitivity (.71) and specificity (.67) and
partial support for the factor structure of the
SCARED in cognitively-able children with ASD seeking
anxiety treatment.
Procedure
Participants, both those with ASD and TD children,
who provided informed consent, and who participated
and successfully completed the early phases of the APP
were asked to return for a battery of behavioral mea-
sures, including the ADOS-2, DAS-II, ADIS/ASA,
CBCL, MASC-P, and SCARED, when they reached
9–13 years of age (Time 4). Diagnostic assessment of
anxiety disorders was conducted only at this middle
childhood timepoint given that anxiety disorders typi-
cally begin to emerge at this age (Beesdo et al., 2009)
and given cross-sectional research suggesting an uptick
in anxiety symptoms during this period in children
with ASD (Davis et al., 2011). The behavioral battery
was completed in multiple, 3 to 4-hour sessions
arranged to accommodate families’ schedules. All inter-
viewers were doctoral level psychologists or students
who were trained to criterion on the ADI-R, ADOS2
and ADIS/ASA.
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Analytic Plan
The presence/absence of clinically significant symp-
toms (ADIS/ASA CSR ≥4) was calculated for each
traditional and distinct anxiety module and children
were categorized based on whether they met criteria
for at least one DSM-specified anxiety disorder
(including and excluding specific phobia), at least
one clinically significant distinct anxiety, both or
neither. Chi Square tests compared rates of clinically
significant anxiety in TD versus ASD, as well in
children with ASD by IQ (< or ≥ 70). In the ASD
sample, nonparametric correlations (Spearman’s ρ)
assessed the association of age and ADOS CSS with
each participant’s highest CSR in the DSM specified
and distinct anxiety categories stratified by IQ group.
An independent sample t-test compared the highest
DSM and distinct CSR respectively by gender.
Sensitivity, specificity, positive and negative predic-
tive values with 95% confidence intervals were calcu-
lated for the SCARED, MASC and CBCL Anxiety
subscale using the ADIS/ASA results as the gold
standard. These metrics are presented using clinically
significant anxiety of either type (DSM-specified or
distinct), DSM-specified only and distinct only as the
criterion in the full sample, broken down by IQ, and
for DSM-specified anxiety only in the higher IQ
group.
Results
Sample Characteristics
Sample characteristics are included in Table 1. Age
did not differ significantly in the TD v. ASD groups.
Children with ASD were significantly more likely to
be male (80%) than TD (62%), X2(1) = 5.2, p = .02.
Intellectual functioning was assessed in 93%
(n = 118) of the sample and revealed broad range
of cognitive functioning in the ASD group (IQ range:
< 25–170, M [SD] = 77.39 [30.81]) versus the TD
groups (IQ range: 83–140, M [SD] = 112.56 [13.62]).
Intellectual testing, though attempted, could not be
completed in 8 youth in the ASD group with mini-
mal to no communication skills. These youth were
included in the intellectual impairment group. In
addition, one youth who demonstrated average intel-
lectual functioning at an earlier time point, (Full
Scale IQ = 98 at 58 months) was categorized as
being without intellectual impairment though he
Table 1. Sample demographic characteristics by diagnostic group (N = 127).
ASD
(n = 75)
TD
(n = 52)
Age in Years, mean (SD) 11.5 (1.0) 11.6 (0.8)
Full Scale IQ1,2, mean (SD) 77.4 (30.8) 112.6 (13.6)a
Male, n (%) 60 (80%) 32 (62%)b
Race3, n (%)
White 52 (71%) 36 (72%)
Black 5 (7%) 0 (0%)
Asian 5 (7%) 4 (8%)
Mixed 7 (10%) 8 (16%)
Other 3 (4%) 2 (4%)
America Indian/Alaska Native 1 (1%) 0 (0%)
Hispanic3, n (%) 17 (23%) 13 (26%)
<30K 12 (17%) 7 (14%)
30 to < 50K 7 (10%) 6 (12%)
50k to < 75K 13 (18%) 8 (16%)
75K to < 100K 14 (20%) 8 (16%)
100K to <150K 16 (23%) 14 (28%)
150K + 9 (13%) 7 (14%)
ADOS Severity Total, mean (SD) 7.9 (1.6) -
SCARED Parent Report Total, mean (SD) 15.6 (11.6) 10.4 (8.3)a
MASC Parent Report Total, mean (SD) 54.3 (12.1) 47.2 (9.0)a
CBCL DSM Anxiety Total, mean (SD) 57.6 (7.6) 52.7 (4.4)a
Level of Education4, n (%) Mother Father Mother Father
No Formal School Completed 1 (2%) 0 (0%) 0 (0%) 0 (0%)
High School or Less 3 (4%) 11 (16%) 5 (10%) 11 (22%)
Some College 12 (18%) 11 (16%) 4 (8%) 6 (12%)
Technical or Associates Degree 16 (24%) 12 (18%) 10 (20%) 7 (14%)
Bachelor’s Degree 26 (38%) 23 (34%) 18 (35%) 17 (33%)
Master’s Degree 8 (12%) 7 (10%) 10 (20%) 8 (16%)
Doctorate 2 (3%) 4 (6%) 4 (8%) 2 (4%)
Missing Data: 1Based on Differential Abilities Scale-2, School-age or Early-years. 2Data missing for 9 ASD participants; 3Data missing for 2 ASD and 2 TD
participants; 4Data missing for 7 ASD and 1 TD participant.
Significant Differences: a Different than ASD group, per independent samples t-test, at p < .01; b Different than ASD group, per chi-square analyses, at p = .02.
All other ASD v TDC comparisons not significant.
Abbreviations: ADOS = Autism Diagnostic Observation Schedule; SCARED = Screen for Anxiety and Related Disorders, Parent Report,
MASC = Multidimensional Anxiety Scale in Children, Parent Report, CBCL = Child Behavior Checklist.
6 C. M. KERNS ET AL.
was unable to complete IQ testing at the school-age
follow-up due to severe disruptive behavior.
Participants had a range of socioeconomic, educa-
tional levels, and racial and ethnic backgrounds,
though over 70% were White/Caucasian and non-
Hispanic in each group (see Table 1). There were
no significant sociodemographic differences in the
TD versus ASD groups.
There were no significant differences in Time 1
developmental quotients or ADOS CSS between the
subset who completed the middle childhood battery
and those who did not (n = 147); demographics were
also similar between these groups (72% male, 54% non-
Hispanic White/Caucasian, 80% male, 44% non-
Hispanic White/Caucasian, respectively).
Rates of DSM-Specified Anxiety Disorders, OCD and
Significant (CSR ≥ 4) Distinct Anxiety Symptoms in
the ASD and TD Groups
Per the ADIS/ASA, children with ASD were signifi-
cantly more likely to present with a DSM anxiety
disorder than the TD group, X2(1) = 26.48, p < .001.
See Table 2. Within TD, 8% met criteria for a DSM
anxiety disorder, including SAD (4%), Specific
Phobia (4%), and Separation Anxiety Disorder (2%;
with one child meeting criteria for multiple anxiety
disorder types). No TD children displayed signifi-
cant distinct anxiety per the ADIS/ASA; however,
one child with a specific phobia diagnosis also had
subclinical (CSR = 3) Fears of Change. Within ASD,
69% displayed clinically significant (CSR ≥ 4) anxi-
ety symptoms, including 21% DSM anxiety disor-
ders alone, 17% distinct anxiety alone, and 31%
with both DSM and distinct anxiety presentations
(Figure 1a and b).
Rates of different DSM anxiety disorders and clini-
cally significant distinct anxiety in the ASD group are
also presented in Table 2. At least one DSM anxiety
disorder or OCD was present in 52% of the ASD
group. DSM anxiety disorders included Specific
Phobia (44%), Generalized Anxiety Disorder (15%),
Separation Anxiety Disorder (7%), and SAD (7%;
including fears of negative evaluation). Four percent
met criteria for OCD. At least one clinically signifi-
cant distinct anxiety was present in 48% of the ASD
group. Distinct anxieties included Fears of Change
(23%), Uncommon Phobias (15%), Other Social
Fears (8%, e.g. social fears unrelated to negative eva-
luation), and Special Interest Fears (7%). In addition,
8% displayed Ambiguous Compulsive Behavior.
Examples included requiring all the doors to be
closed in the house and requesting that someone
draw something repetitively in a specific way then
cross it out while displaying distress. Clinically sig-
nificant negative reactions to change – that is, diffi-
culties coping with change without anticipatory fears
or worries about change were also identified in 9% of
children. Notably, 45% (n = 34) of children were
described as having fears of or negative reactions to
change by their parents, but only 32% of these were
considered clinically significant.
For those with ASD and DSM anxiety disorders,
17% (n = 13) had more than one – all but one of
whom had IQ > 70 – and 59% (n = 23) also had
clinically significant distinct anxiety. For those with
clinically significant distinct anxiety, 64% (n = 23)
also had a DSM anxiety disorder.
Table 2. Rates of DSM anxiety disorders, OCD and clinically-significant (CSR>3) distinct anxiety in ASD and TD groups per the ADIS/ASA.
TD ASD
All IQ IQ < 70 IQ ≧ 70
N = 52 N = 75 N = 36 N = 39
DSM Anxiety or OCD 4 (8%) 39 (52%)a 17 (47%) 22 (56%)b
DSM Anxiety (excluding phobia) & OCD 3 (6%) 17 (23%)a 3 (18%) 14 (36%)c
Separation Anxiety Disorder 0 (0%) 5 (7%) 2 (6%) 3 (8%)
SAD 2 (4%) 5 (7%) 0 (0%) 5 (13%)
Specific Phobia 2 (4%) 33 (44%) 15 (42%) 18 (46%)
Generalized Anxiety Disorder 1 (2%) 11 (15%) 0 (0%) 11 (28%)
OCD 0 (0%) 3 (4%) 1 (3%) 2 (5%)
Clinically Sig. Distinct Anxiety 0 (0%) 36 (48%) 17 (47%) 19 (49%)b
Other Social Fear 0 (0%) 6 (8%) 3 (7%) 3 (8%)
Uncommon Phobias 0 (0%) 11 (15%) 5 (14%) 6 (15%)
Special Interest Fear 0 (0%) 5 (7%) 1 (3%) 4 (10%)
Fears of Change 0 (0%) 17 (23%) 7 (19%) 10 (26%)
Ambiguous OCD 0 (0%) 6 (8%) 5 (14%) 1 (3%)
Other Difficulties
Negative Reactions to Change
0 (0%) 7 (9%) 3 (8%) 4 (11%)
OCD = Obsessive Compulsive Disorder. aSignificantly different than TDC at p ≤ .01; bNot significantly different than IQ < 70 group. c Significantly different
than IQ < 70 group at p < .01 Statistical comparisons not conducted for clinically significant distinct anxiety in TDC v. ASD group or individuals diagnoses
given that some cells had zero cases.
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For 29% (n = 22) of children with ASD, the only DSM-
anxiety disorder diagnosed was a specific phobia. As such,
rates of DSM anxiety disorders changed substantially
when this presentation was excluded (Figure 1c): 57%
presented with clinically significant anxiety, including
only 9% DSM anxiety disorders alone, 35% distinct anxi-
ety alone, and 13% with both (23% with DSM anxiety
disorders and 48% with distinct anxiety disorder overall).
Intellectual Impairment and Clinically Significant
Anxiety in ASD
Rates of DSM anxiety disorders and clinically signifi-
cant distinct anxiety were compared in youth with ASD
with and without intellectual impairment (GCA<70 or
GCA ≧ 70 respectively, on DAS-II; Table 2). Rates of
both DSM-anxiety disorders (47% v. 56%, ns) and
No Anxiety 
Disorder 
92% (48)
DSM Anxiety 
8% (4)
a. Rates (%[n]) of Clinically Significant Anxiety 
(Including Phobias) in TD Group (N=52) 
No Anxiety 
Disorder
31% (23)
DSM Anxiety
21% (16)
Distinct 
Anxiety 
17% (13)
DSM & Distinct 
Anxiety
31% (23)
b. Rates (%[n]) of Clinically Significant Anxiety 
(Including Phobias) in ASD Group (N=75)
No Anxiety 
Disorder
43% (32)
DSM Anxiety
9% (7)
Distinct Anxiety 
35% (26)
DSM and 
Distinct Anxiety 
13% (10)
c. Rates (%[n]) of Clinically Anxiety (Excluding 
Phobias) in ASD Group (N=75)
Figure 1. (a). Rates (%[n]) of clinically significant anxiety (including phobias) in TD group (N = 52). (b). Rates (%[n]) of clinically significant
anxiety (including phobias) in ASD group (N = 75). (c). Rates (%[n]) of clinically anxiety (excluding phobias) in ASD group (N = 75).
TD = Typically Developing Children; ASD = Autism Spectrum Disorder.
All categories determined by Anxiety Disorders Interview Schedule/Autism Spectrum Addendum.
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distinct anxiety (47% v. 49%, ns) were not significantly
different for children with or without intellectual
impairment. However, the vast majority of DSM anxi-
ety disorders in children with IQ<70 were specific
phobias, while DSM anxiety disorders (other than pho-
bia) were significantly less common in children with
(8%) versus without (36%) intellectual impairment (X2
(1) = 8.11, p < .01). That is, the similar rate of DSM
anxiety in both low and high IQ groups appeared to be
driven by a high rate of specific phobias, as opposed to
other forms of DSM anxiety, in children with intellec-
tual impairment. Specific phobia was diagnosed at simi-
lar rates in both groups (42% and 46%, respectively).
Rates of other types of DSM anxiety disorder were too
low in the intellectually impaired group for statistical
comparison. There were no significant differences in
specific distinct anxiety presentations by IQ status.
Child Characteristics Associated with Clinically
Significant Anxiety in ASD
The highest CSR given for any DSM anxiety on the
ADIS/ASA was significantly correlated with the highest
CSR given for any distinct anxiety in children without
(Spearman’s ρ = 0.39, p = .01), but not with intellectual
impairment (Spearman’s ρ = 0.02, ns) in the ASD
group. Neither DSM, nor distinct anxiety CSR were
significantly correlated with ADOS severity or age in
children with ASD, regardless of IQ status. Neither
differed significantly by gender. A series of post-hoc,
one-way ANOVA suggested no significant differences
in age, ASD severity (ADOS SA and RRB comparison
scores), IQ or overall anxiety severity (top CSR on
ADIS/ASA) for children with distinct alone, DSM-
alone or mixed presentations of clinical anxiety; how-
ever, these groups were relatively small and thus there
was limited power to detect differences.
Concordance of Clinical Interviews with Brief
Parent Report Measures
We next calculated the sensitivity, specificity, PPV and
NPV of the parent-report MASC total, SCARED total
and CBCL DSM Anxiety Problem subscale total in
detecting cases with clinically significant anxiety overall
and by presentation (DSM v. distinct) based on the
ADIS/ASA (see Table 3). Whereas specificity (76.5%–
100% across measures) was strong, sensitivity (0%–
61.9%) and NPV (33.3%–61.9%) were generally weak.
PPV was mixed, appearing stronger for any significant
anxiety (87.5%–92.3%) and DSM anxiety disorders
(68.8%–86.7%) than for distinct anxiety (53.8%–69.2%).
Child IQ and verbal IQ were significantly correlated
with total scores on the SCARED, MASC and CBCL
Anxiety Problems Subscale (Table 4). Sensitivity was
poorest for detecting any significant anxiety in cases
with intellectual impairment (0%–0.13); the majority of
cases in this group were missed. When restricting the
sample to children without intellectual impairment,
specificity was maintained (83.3%–91.7%) and
Table 3. Concordance of brief parent report measures with ADIS/ASA.
ADIS/ASA Determination1
SCARED (N = 70)
%(95% CI)
MASC (N = 71)
%(95% CI)
CBCL Anxiety Subscale (n = 71)
%(95% CI)
Any Clinically Significant Anxiety Sensitivity 29.2 (28.8, 29.6) 31.3 (30.8, 31.7) 24.5 (24.1, 24.9)
Specificity 90.9 (90.5, 91.3) 91.3 (90.9, 91.7) 95.5 (95.2, 95.7)
PPV 87.5 (87.0, 88.0) 88.2 (87.7, 88.7) 92.3 (91.8, 92.8)
NPV 37.0 (36.6, 37.4) 38.9 (38.5, 39.3) 36.2 (35.8, 36.6)
DSM Anxiety Disorder Sensitivity 31.4 (30.9, 31.9) 37.1 (36.6, 37.7) 30.6 (30.1, 31.1)
Specificity 85.7 (85.3, 86.1) 94.1 (93.9, 94.4) 94.3 (94.0, 94.5)
PPV 68.8 (68.0, 69.5) 86.7 (86.2, 87.2) 84.6 (84.0, 85.2)
NPV 55.6 (55.1, 56.0) 59.3 (58.8, 59.7) 56.9 (56.5, 57.3)
Clinically Significant Distinct Anxiety Sensitivity 29.4 (28.9, 29.9) 26.4 (26.0, 26.9) 20.6 (20.2, 21.0)
Specificity 83.3 (82.9, 83.7) 88.9 (88.6, 89.2) 83.8 (83.4, 84.2)
PPV 62.5 (61.7, 63.3) 69.2 (68.4, 70.0) 53.8 (53.0, 54.7)
NPV 55.6 (55.1, 56.0) 56.1 (55.7, 56.6) 53.5 (53.1, 53.9)
Any Clinically Significant Anxiety, IQ < 70, N = 33 Sensitivity 9.1 (8.7, 9.5) 0.0 13.0 (12.6, 13.5)
Specificity 90.9 (90.4, 91.5) 1.00 1.00
PPV 66.7 (65.0, 68.4) NaN2 1.00
NPV 33.3 (32.8, 33.9) 33.3 (32.8, 33.8) 33.3 (32.8, 33.9)
Any Significant Anxiety, IQ≧70, N = 38 Sensitivity 46.2 (90.9, 90.4) 57.7 (57.1, 58.3) 34.6 (34.0, 35.2)
Specificity 90.9 (90.4, 91.5) 83.3 (82.7, 84.0) 91.7 (91.2, 92.2)
PPV 92.3 (91.8, 92.8) 88.2 (87.7, 88.7) 90.0 (89.4, 90.6)
NPV 41.7 (41.0, 42.3) 47.6 (46.9, 48.3) 39.3 (38.7, 39.9)
DSM Anxiety Disorder, IQ≧70, N = 38 Sensitivity 52.3 (51.7, 53.1) 61.9 (61.2, 62.6) 42.9 (42.2, 43.5)
Specificity 87.5 (87.0, 88.0) 76.5 (75.8, 77.1) 94.1 (93.8, 94.5)
PPV 84.6 (94.0, 85.2) 76.5 (75.8, 77.1) 90.0 (89.4, 90.6)
NPV 58.3 (57.7, 59.0) 61.9 (61.2, 62.6) 57.1 (56.6, 57.7)
1ADIS/ASA determinations were considered the gold standard in these analyses. 2NaN = Not a number; could not be calculated given that the MASC did not
correctly identify any children in this subsample with clinically significant anxiety. ADIS/ASA = Anxiety Disorders Interview Schedule/Autism Spectrum
Addendum; SCARED = Screen for Anxiety and Related Emotional Disorders, Parent Report; MASC = Multi-dimensional Anxiety Scale for Children, Parent
Report; CBCL = Child Behavior Checklist, DSM Anxiety Problems Subscale.
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sensitivity improved, but not to satisfactory levels
(34.6%–57.7%). All measures were most sensitive in
detecting DSM anxiety disorders in children without
intellectual impairment (the group most similar to that
for whom these measures were designed), yet sensitivity
(42.9%–61.9%) and NPV (57.1%–61.9%) remained
modest. Sensitivity for detecting children with DSM
anxiety disorders other than simple, specific phobia
was also modest (CBCL 38%; MASC 63%;
SCARED 44%).
Discussion
The extent to which anxiety disorder estimates in chil-
dren with ASD are biased by the inconsistent differen-
tiation of anxiety and ASD symptoms is unclear (Kerns
& Kendall, 2012). The present study used a rigorous,
tailored examination of DSM-specified anxiety disor-
ders and other “distinct” forms of problematic anxiety
in a well-characterized, intellectually diverse sample to
provide more precise and nuanced estimates of anxiety
disorders in ASD and evaluate how anxiety presenta-
tion and intellectual impairment contribute to mea-
surement bias. Youth were assessed in middle
childhood, given research suggesting that anxiety dis-
orders typically begin to emerge at this age (Beesdo
et al., 2009).
Findings affirm that DSM-specified anxiety disor-
ders are prevalent and significantly more common in
ASD (52%) versus TD (8%), even when diagnostic
criteria are strictly applied and care is taken to differ-
entiate overlapping and ambiguous symptoms. This
rate falls within the range reported in other studies of
DSM-specified anxiety disorders in population-based
(42%) and outpatient samples of children with ASD
(55%; de Bruin et al., 2007; Simonoff et al., 2008) and
strengthens these findings. Specifically, in contrast to
prior work, the interview used in this study collected
additional information regarding relevant features of
ASD in order to minimize errors in differential diag-
nosis (e.g. overshadowing of anxiety by autism symp-
toms or over-attribution of autism-related deficits to
anxiety) and provide refined estimates of clinical
anxiety.
The presence of distinct or idiosyncratic fears in
ASD has repeatedly been documented, but rarely sys-
tematically assessed (see Magiati, Ozsivadjian, & Kerns,
2017). Present findings align with a prior study (Kerns
et al., 2014) in suggesting that almost 50% of children
with ASD present with functionally impairing fears and
worries that differ qualitatively from DSM-specified
diagnoses, including excessive fears related to change
(23%), idiosyncratic stimuli (e.g. toilets, songs; 15%),
social confusion rather evaluation (8%), and special
interests (7%). In addition, 8% of children presented
with compulsive behaviors, which though negative in
valence, did not clearly serve a neutralizing function (as
is characteristic in OCD). Of those children with ASD
and clinically significant anxiety, 69% had distinct
symptoms. In addition, almost two-thirds of children
with distinct anxiety also had DSM-specified anxiety
disorders. This suggests that distinct and DSM presen-
tations commonly co-occur in ASD, a consistent find-
ing across studies (Kerns et al., 2014, 2017).
Findings are consistent with a recent study which
found fears of uncertainty to be the most common
expressions of anxiety in children with ASD (Keen,
Adams, Simpson, Den Houting, & Roberts, 2019) and
with a significant canon of work demonstrating a close
relationship between anxiety and intolerance of uncer-
tainty in ASD (Boulter, Freeston, South, & Rodgers,
2014; Chamberlain et al., 2013; Wigham, Rodgers,
South, McConachie, & Freeston, 2015). In the present
sample, fears or negative reactions to change were
reported in 45% and deemed clinically significant in
32%; only specific phobias were more common (44%).
The rate of additional uncommon phobias (e.g. fears of
bubbles, songs; 15%) was also similar to that found in
Kerns et al. (2014), but lower than the 41% reported by
Mayes et al. (2013), who did not assess the severity of
fears and conceptualized a broader range of fears as
unusual (e.g. heights, weather, small spaces) in their
estimate. Overall, findings indicate that reliance on
DSM-specified anxiety disorders alone may result in
substantial underestimation and incomplete characteri-
zation of impairing anxiety problems in children with
ASD. The few studies to use anxiety measures, which are
developed for children with ASD and also query about
fears of uncertainty, sensory and non-evaluative social
fears, are thus far consistent in suggesting that clinical
anxiety occurs in closer to two-thirds of children with
ASD (Den Houting, Adams, Roberts, & Keen, 2018;
Kerns et al., 2014) as opposed to the range of 40–55%
suggested by studies using un-adapted measures (de
Table 4. Pearson correlations (R[n]) between IQ, verbal IQ with brief measures of anxiety.
SCARED Total MASC Total CBCL Anxiety Problems Total
IQ 0.48* (61) 0.55* (62) 0.38* (63)
Verbal IQ 0.49* (56) 0.50* (57) 0.39* (58)
*p < .01. Given some missing data, the sample size for each correlation is indicated as R(n).
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Bruin et al., 2007; Gjevik et al., 2011; Simonoff et al.,
2008; van Steensel et al., 2011).
Our TD comparison group provided two additional
important findings: (1) clinically significant distinct
anxiety was not reported in children without ASD
(though subclinical fears of change were reported in 1
child), and (2) rates of DSM-anxiety disorders were in
the expected range (8%) for this age group (Costello,
Egger, & Angold, 2005). Fears and intolerance of uncer-
tainty are well-documented in children with anxiety
disorders and associated with worry and anxiety in
nonclinical populations (Osmanağaoğlu, Creswell, &
Dodd, 2018). Though these fears are not unique to
ASD, as noted above, they may be distinctly prominent
and exaggerated (e.g. Donald’s fear of the setting sun).
Future comparisons with other, high risk groups that
share some similarities with ASD, such as children with
other developmental delays (e.g. Fragile X, Down’s
syndrome), attention-deficit hyperactivity disorder and
specific language impairments may illuminate the
extent to which children with ASD demonstrate
a truly unique vulnerability and profile of anxiety.
The second aim of this study was to examine how
intellectual impairment is related to the expression and
detection of significant anxiety in ASD. The research
literature has been inconclusive regarding the relation-
ship of intellectual functioning to anxiety disorder risk
in ASD. Consistent with the hypotheses of Kerns and
Kendall (2012), the present results suggest a nuanced
relationship between a child’s developmental level and
the quality, but not the quantity of anxiety symptoms in
children with ASD. That is, for children with intellec-
tual impairment (and thus lower mental age), the only
DSM-anxiety diagnoses given were specific phobias
(42%) and separation anxiety disorder (6%) – anxiety
disorders which research suggests have the earliest age
of onset in childhood (Beesdo et al., 2009). OCD was
also diagnosed in 3% of these youth. By contrast, the
full range of childhood DSM-anxiety disorders were
seen in children with ASD and IQ>70. These findings
suggest that positive associations between IQ and anxi-
ety in ASD, as seen for all parent-report measures of
anxiety in this study, may be misleading and result
from a reduced sensitivity to detect the expression of
anxiety in developmentally immature youth. Though
there were no significant differences in the rates of
DSM anxiety disorders or distinct anxiety by IQ status,
DSM-anxiety disorders other than specific phobia were
significantly less common in children with (18%) ver-
sus without (35.7%) intellectual impairment. Findings
are consistent with prior research demonstrating
a significant relationship between certain types of anxi-
ety (e.g. GAD) and IQ in ASD, but not others (e.g.
phobia, avoidance; Sukhodolsky et al., 2008) and
between greater language ability (often associated with
IQ) and DSM-specified, but not distinct anxiety symp-
toms (Kerns et al., 2014).
The relative predominance of specific phobia and
distinct anxiety presentation in autistic children with
v. without ID has substantial measurement implica-
tions. Most brief measures of anxiety in school-age
youth inquire broadly about DSM anxiety disorders
and thus may be less sensitive to this more constrained
and distinctive presentation. Consistent with this
hypothesis, all brief parent-report measures of anxiety
included in this study had limited sensitivity to detect
clinically significant anxiety in the ASD group, particu-
larly amongst children with ID, for whom almost all
cases were missed. Yet, this explanation is likely not
sufficient as sensitivities for detecting cases with DSM
anxiety disorders other than specific phobia in this
study were also modest. By contrast, a prior study
found that the CBCL anxiety problems subscale
detected 83% of ASD cases with an anxiety diagnosis
(Magyar & Pandolfi, 2017). As such, further research is
needed to understand what may account for these dis-
crepancies in the CBCL’s detection of affective pro-
blems in ASD across studies (see also Medeiros et al.,
2017; Pandolfi et al., 2012).
Whereas some studies suggest that the construct of
anxiety may not be adequately captured by standard
anxiety questionnaires (Dovgan, Mazurek, & Hansen,
2019; Jitlina et al., 2017; Kerns, Maddox, et al., 2015;
White et al., 2015), others have reported adequate
psychometric properties in ASD samples (Stern et al.,
2014; van Steensel, Deutschman, & Bögels, 2013). Our
findings suggest that these tools are likely most appro-
priate for detecting DSM anxiety in children with ASD
and minimal intellectual impairments – a subgroup of
children with ASD upon which most affirmative stu-
dies have focused. A recent study found that few
children seeking cognitive-behavioral treatment
(CBT) for anxiety presented with solely distinct symp-
toms; rather the majority had DSM-specified disor-
ders, both with and without clinically significant
distinct anxiety (Kerns et al., 2017). The focus on
treating DSM-specified anxiety disorders in cogni-
tively-able children in these studies may explain why
measures like the SCARED and MASC have proven
useful and sensitive to treatment (Reaven, Blakeley-
Smith, Culhane-Shelburne, & Hepburn, 2012; Wood
et al., 2015). Nonetheless, current findings suggest that
these measures may fall short in detecting clinical
anxiety amongst children with ASD who are not treat-
ment seeking (i.e. relatively low risk samples) or who
have co-occurring intellectual impairment. Moreover,
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they suggest these measures may tell an incomplete
story even about the anxiety of verbal children with
ASD and DSM-specified anxiety, many of whom will
also present with additional, distinctive fears and
worries.
Limitations
Though the ADIS/ASA incorporates clinical judg-
ment, clinicians were constrained in their judgments
to information provided by the parent in this study.
Self and teacher reports of internalizing symptoms,
like anxiety, often differ in youth with (Blakeley-
Smith, Reaven, Ridge, & Hepburn, 2012; Kaat &
Lecavalier, 2015) and without ASD (Miller, Martinez,
Shumka, & Baker, 2014), and these differences in
perspective may provide important, complementary
insights regarding the expression and pervasiveness
of a child’s symptoms (De Los Reyes & Kazdin,
2005). Future studies should examine differences in
the prevalence of symptoms based on parent, child
and composite (diagnoses endorsed by parent or
child) reports and also what mental age and verbal
abilities may be required for various child and parent
report measures to be useful. Additional limitations
include the small number of nonwhite and female
children with ASD in this sample, which constrains
the generalizability of our results to children with
similar sociodemographic characteristics and may
have prohibited detection of gender differences.
Clinical Implications and Future Directions
It has been hypothesized that anxiety in ASD may
reflect an artifact of phenotypic overlap, or a distinct
co-occurring condition, either similar (e.g. comorbid-
ity) or varied in presentation from monomorbid anxi-
ety (Kerns & Kendall, 2012; Wood & Gadow, 2010).
Our results add to a wealth of studies indicating
a prevalence of anxiety symptoms that can be reliably
differentiated and appear to reflect a distinct construct
from ASD and support the hypothesis that anxiety
conditions manifest in both a traditional and distinct
manner in ASD (Kerns & Kendall, 2012; Renno &
Wood, 2013). Distinct anxiety, though thematically
related to ASD symptoms (e.g., insistence on same-
ness, sensory difficulties), had a stronger relationship
to DSM anxiety than ASD severity. Whereas distinct
anxiety was not significantly associated with ASD
severity (in children of either IQ group), it was asso-
ciated with DSM anxiety in intellectually-able children
with ASD. DSM and distinct anxiety were not signifi-
cantly associated in children with ASD and intellectual
impairment, but this may be explained by the limited
amount and variety of DSM anxiety in this group.
Moreover, the base rates of significant distinct anxiet
(6–23%) were not consistent with their being concep-
tualized as integral or inevitable consequences of ASD
(Folstein, 2012). Kerns et al. (2014) also reported that
significant DSM and distinct anxiety occur in
a substantial subset, but not all, children with ASD
and were more strongly related to one another than
ASD severity. Finally, a growing number of research-
ers, content experts, parents and verbal individuals
with ASD are advocating for the behaviors described
here as “distinct anxiety” to be recognized as fears and
worries (Magiati et al., 2017; Robertson et al., 2018)
and distinct expressions of anxiety are increasingly
being incorporated into adapted measures (Kerns
et al., 2017; Rodgers et al., 2016; Scahill et al., 2019).
In support of this movement, the present findings
reiterate not only the fearful and anxious quality of
these symptoms, but also their association with sig-
nificant additional functional impairment for many
children with ASD.
With regard to future directions, assessing a broader
range of anxiety problems in ASD with greater accuracy
may shed light on how anxiety relates to the phenotype
and developmental trajectory (Baribeau et al., 2019)
and outcomes of children with ASD (Kerns, Kendall,
et al., 2015; Lecavalier et al., 2017; Pellecchia et al.,
2016; van Steensel et al., 2012) and aid in the identifica-
tion of anxiety biomarkers, such as physiological
(Hollocks, Howlin, Papadopoulos, Khondoker, &
Simonoff, 2014) and amygdala responses (Herrington
et al., 2017), in ASD. Accurate assessment is also critical
to ensure that the full range of children suffering from
anxiety problems are identified and given access to
appropriate interventions. An important next step to
achieving this goal will be determining if distinct anxi-
ety presentations require a tailored intervention
approach (Wood et al., 2015) or a focus on potential
transdiagnostic mechanisms like intolerance of uncer-
tainty (Rodgers et al., 2017). Finally, to achieve more
accurate diagnosis and treatment in community set-
tings, it will be important to understand the extent to
which ASD providers perceive anxiety disorders in
their clients and how these perceptions are shaped by
provider (e.g., discipline, experience), child (e.g., intel-
lectual functioning, gender, expression of anxiety) and
structural characteristics (e.g., the ability to assign an
appropriate diagnostic code; Wainer et al., 2017).
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